{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:09:49Z","timestamp":1792696189594,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018602","name":"Guangxi Innovation-Driven Development Project","doi-asserted-by":"publisher","award":["GuiKe AA18242040"],"award-info":[{"award-number":["GuiKe AA18242040"]}],"id":[{"id":"10.13039\/501100018602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejmech.2026.118759","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:03:51Z","timestamp":1773126231000},"page":"118759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rational design, synthesis and effective mechanism of sophoridine and matrine contains 2,3,4-triphenylpyridine derivatives as Topo\u2160 inhibitors for the treatment of gastric carcinoma"],"prefix":"10.1016","volume":"309","author":[{"given":"Gan","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2655-0724","authenticated-orcid":false,"given":"Lisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejmech.2026.118759_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41580-022-00452-3","article-title":"Human topoisomerases and their roles in genome stability and organization","volume":"23","author":"Pommier","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118759_bib2","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1021\/acs.jmedchem.6b00966","article-title":"Type I DNA topoisomerases","volume":"60","author":"Capranico","year":"2017","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118759_bib3","first-page":"539","article-title":"Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy","volume":"54","author":"Husain","year":"1994","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118759_bib4","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1158\/1535-7163.MCT-09-0016","article-title":"Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity","volume":"8","author":"Pfister","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118759_bib5","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/0008-5472.CAN-09-3528","article-title":"Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron","volume":"70","author":"Reinhold","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118759_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0167-4781(95)00171-9","article-title":"Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung","volume":"1264","author":"Giaccone","year":"1995","journal-title":"Biochim. Biophys. Acta Gene Struct. Expr."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118759_bib7","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1021\/cr900097c","article-title":"DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition","volume":"109","author":"Pommier","year":"2009","journal-title":"Chem. Rev."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118759_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543770902773437","article-title":"Novel camptothecin derivatives as topoisomerase I inhibitors","volume":"19","author":"Basili","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4933","key":"10.1016\/j.ejmech.2026.118759_bib9","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1126\/science.2555920","article-title":"DNA topoisomerase I\u2014targeted chemotherapy of human Colon cancer in xenografts","volume":"246","author":"Giovanella","year":"1989","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118759_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/mol.52.1.82","article-title":"Novel 7-Alkyl methylenedioxy-camptothecin derivatives exhibit increased cytotoxicity and induce persistent cleavable complexes both with purified Mammalian topoisomerase I and in human Colon carcinoma SW620 cells","volume":"52","author":"Valenti","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118759_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s002800000157","article-title":"Camptothecin analogues with enhanced antitumor activity at acidic pH","volume":"46","author":"Adams","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118759_bib12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jvir.2015.03.020","article-title":"Transarterial hepatic chemoembolization with 70\u2013150 <strong>\u03bc<\/strong>m drug-eluting beads: assessment of clinical safety and liver toxicity profile","volume":"26","author":"Odisio","year":"2015","journal-title":"J. Vasc. Intervent. Radiol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118759_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/bmc.805","article-title":"LC-MS characterization of efficacy substances in serum of experimental animals treated with Sophora flavescens extracts","volume":"21","author":"Ye","year":"2007","journal-title":"Biomed. Chromatogr."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118759_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/bmc.348","article-title":"High-performance liquid chromatographic method for simultaneous determination of sophoridine and matrine in rat plasma","volume":"18","author":"Li","year":"2004","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejmech.2026.118759_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153756","article-title":"Sophoridine: a review of its pharmacology, pharmacokinetics and toxicity","volume":"95","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118759_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchromb.2006.05.023","article-title":"A rapid reversed phase high-performance liquid chromatographic method for determination of sophoridine in rat plasma and its application to pharmacokinetics studies","volume":"843","author":"Wei","year":"2006","journal-title":"J. Chromatogr. B"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118759_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/acsmedchemlett.6b00466","article-title":"Synthesis, biological evaluation, and autophagy mechanism of 12N-Substituted sophoridinamines as novel anticancer agents","volume":"8","author":"Bi","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118759_bib18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.bmcl.2015.09.010","article-title":"Alkaloids from Oxytropis ochrocephala and antiproliferative activity of sophoridine derivatives against cancer cell lines","volume":"26","author":"Tan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"19","key":"10.1016\/j.ejmech.2026.118759_bib19","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1016\/j.bmcl.2015.08.035","article-title":"Synthesis, structure\u2013activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents","volume":"25","author":"Li","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118759_bib20","first-page":"156","article-title":"Study on isolation of chemical constituents from Sophora Flavescens ait. And their anti-glioma effects","volume":"11","author":"Zheng","year":"2013","journal-title":"Afr. J. Tradit., Complementary Altern. Med."},{"key":"10.1016\/j.ejmech.2026.118759_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nanoen.2020.104641","article-title":"Energy transfer and wavelength tunable lasing of single perovskite alloy nanowire","volume":"71","author":"Tang","year":"2020","journal-title":"Nano Energy"},{"key":"10.1016\/j.ejmech.2026.118759_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejmech.2018.07.028","article-title":"Novel indolo-sophoridinic scaffold as Topo I inhibitors: design, synthesis and biological evaluation as anticancer agents","volume":"156","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118759_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ejmech.2018.08.021","article-title":"Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents","volume":"157","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118759_bib24","first-page":"222","article-title":"[Determination of matrine, sophoridine and oxymatrine in compound Kushen injection by HPLC]","volume":"32","author":"Tian","year":"2007","journal-title":"Zhongguo Zhongyao Zazhi"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118759_bib25","article-title":"Antitumor activities of Kushen: literature review","volume":"2012","author":"Sun","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118759_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bmcl.2018.01.017","article-title":"Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents","volume":"28","author":"Li","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"17","key":"10.1016\/j.ejmech.2026.118759_bib27","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1016\/j.bmcl.2016.07.045","article-title":"Synthesis and biological evaluation of matrine derivatives as anti-hepatocellular cancer agents","volume":"26","author":"Wu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.118759_bib28","series-title":"Characterization and Activity Evaluation of Matrinic Acid Derivatives as Potential Antiproliferative Agents Molecules","first-page":"5420","author":"Chao","year":"2013"},{"issue":"12","key":"10.1016\/j.ejmech.2026.118759_bib29","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.bmcl.2015.04.051","article-title":"Design, synthesis and anticancer activity of matrine\u20131H-1,2,3-triazole\u2013chalcone conjugates","volume":"25","author":"Zhao","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118759_bib30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3892\/mmr.2016.5999","article-title":"Matrine-induced apoptosis in Hep3B cells via the inhibition of MDM2","volume":"15","author":"Zhou","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118759_bib31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/10408347.2022.2089839","article-title":"Medicinal importance and chemosensing applications of pyridine derivatives: a review","volume":"54","author":"Mohammad Abu-Taweel","year":"2024","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118759_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10593-006-0137-8","article-title":"Synthesis, characterization, and biological activities of some 3,5,6-trichloropyridine derivatives","volume":"42","author":"Chavan","year":"2006","journal-title":"Chem. Heterocycl. Compd."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118759_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1134\/S1019331610020061","article-title":"Developing state-of-the-art antiseptics based on pyridine derivatives","volume":"80","author":"Savchenko","year":"2010","journal-title":"Herald Russ. Acad. Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118759_bib34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00044-010-9440-0","article-title":"Synthesis and antimicrobial activity of new pyridine derivatives-I","volume":"20","author":"Patel","year":"2011","journal-title":"Med. Chem. Res."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118759_bib35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1026181918567","article-title":"Pyridine oximes: synthesis, reactions, and biological activity","volume":"39","author":"Abele","year":"2003","journal-title":"Chem. Heterocycl. Compd."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118759_bib36","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/ejic.200700030","volume":"2007","author":"Vr\u00e1bel","year":"2007","journal-title":"Eur. J. Inorg. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118759_bib37","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1007\/s00044-011-9903-y","article-title":"Antioxidant, cytotoxicity, and QSAR study of 1-adamantylthio derivatives of 3-picoline and phenylpyridines","volume":"21","author":"Worachartcheewan","year":"2012","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118759_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5012\/bkcs.2011.32.1.303","article-title":"Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of rigid analogues of 2,4,6-Trisubstituted pyridine containing 5,6-Dihydrobenzo[h]quinoline moiety","volume":"32","author":"Jeong","year":"2011","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118759_bib39","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejmech.2017.07.050","article-title":"Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy","volume":"138","author":"Yuan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118759_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-34464-6","article-title":"The splanchnic mesenchyme is the tissue of origin for pancreatic fibroblasts during homeostasis and tumorigenesis","volume":"14","author":"Han","year":"2023","journal-title":"Nat. Commun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:19:32Z","timestamp":1784668772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"alternative-id":["S0223523426002047"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118759","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design, synthesis and effective mechanism of sophoridine and matrine contains 2,3,4-triphenylpyridine derivatives as Topo\u2160 inhibitors for the treatment of gastric carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118759"}}